PDF) Evaluation préclinique d'une nouvelle stratégie de radiosensibilisation pharmacologique : l'inhibition des histones désacétylases

Les resultats insuffisants de la radiochimiotherapie conventionnelle dans les cancers bronchiques non a petites cellules (CBNPC) ont motive l’evaluation d’une nouvelle strategie de modulation pharmacologique de la radiosensibilite tumorale basee sur

Full article: Design, synthesis and biological evaluation of novel histone deacetylase (HDAC) inhibitors derived from β-elemene scaffold

PDF) Histone Deacetylase Inhibitors: Advancing Therapeutic Strategies in Hematological and Solid Malignancies

PDF) Histone Deacetylase Inhibitors: Advancing Therapeutic Strategies in Hematological and Solid Malignancies

Full article: Design, synthesis and biological evaluation of novel histone deacetylase (HDAC) inhibitors derived from β-elemene scaffold

PDF) Radio-immunothérapie par antigène carcino embryonnaire (ACE) marqué à l'iode 131I-labetuzumab après chirurgie de sauvetage des métastases hépatiques de cancer colorectal

Targeting histone deacetylases for cancer therapy: Trends and challenges - ScienceDirect

Frontiers Evaluation of Histone Deacetylase Inhibitors as Radiosensitizers for Proton and Light Ion Radiotherapy

Targeting histone deacetylases for cancer therapy: Trends and challenges - ScienceDirect

A large scale mass spectrometry-based histone screening for assessing epigenetic developmental toxicity

Full article: Design, synthesis and biological evaluation of novel histone deacetylase (HDAC) inhibitors derived from β-elemene scaffold

Targeting histone deacetylases for cancer therapy: Trends and challenges - ScienceDirect

Targeting histone deacetylases for cancer therapy: Trends and challenges - ScienceDirect

Frontiers Evaluation of Histone Deacetylase Inhibitors as Radiosensitizers for Proton and Light Ion Radiotherapy

PDF) Histone Deacetylase Inhibitors as Novel Anti-Cancer Therapeutics